Correlation Between Mineralys Therapeutics, and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Mineralys Therapeutics, and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and LMF Acquisition.
Diversification Opportunities for Mineralys Therapeutics, and LMF Acquisition
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and LMF is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and LMF Acquisition go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and LMF Acquisition
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.39 times more return on investment than LMF Acquisition. However, Mineralys Therapeutics, Common is 2.59 times less risky than LMF Acquisition. It trades about -0.06 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about -0.07 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 29, 2024 and sell it today you would lose (137.00) from holding Mineralys Therapeutics, Common or give up 9.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. LMF Acquisition Opportunities
Performance |
| Timeline |
| Mineralys Therapeutics, |
| LMF Acquisition Oppo |
Mineralys Therapeutics, and LMF Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and LMF Acquisition
The main advantage of trading using opposite Mineralys Therapeutics, and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
| LMF Acquisition vs. Eliem Therapeutics | LMF Acquisition vs. Scpharmaceuticals | LMF Acquisition vs. Milestone Pharmaceuticals | LMF Acquisition vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |